Treating Male Breast Cancer Patients

Treating Male Breast Cancer Patients

Cancer-News

1 month
6 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Xiao-Ou Shu, MD of @VUMChealth explains how oncologists should treat male breast cancer patients and how it will affect clinicians.

_______

Men may be more likely than women to die after being diagnosed with breast cancer, particularly during the first 5 years after diagnosis, a new study suggests. 

In the study, the 5-year overall survival rate after a diagnosis of breast cancer was 77.6% for men, compared with 86.4% for women, researchers reported in JAMA Oncology on September 19. 

The findings add to previous research showing differences in death rates between men and women with breast cancer while also providing information about some of the factors that may contribute to the disparity between the sexes.

One factor identified by the authors was the lack of adequate treatment for many men with breast cancer, a phenomenon known as undertreatment. Another was the later diagnosis of the disease in men than in women. 

Differences in clinical characteristics, such as the types and stage of breast tumors, age at diagnosis, and cancer treatment between men and women with breast cancer played a major role, accounting for 63% of mortality disparity, the researchers reported. However, after all those factors were accounted for, male patients still had 19% higher chance of dying than female patients within 5 years of diagnosis. 

“We were not able to investigate other known or suspected contributors for the disparity in death rates in this study, such as compliance to cancer treatment, tumor genetics, and lifestyle factors, such as obesity, smoking, and alcohol use,” said Xiao-Ou Shu, M.D., Ph.D., of Vanderbilt-Ingram Cancer Center, who led the research. 

“If we want to learn more about why outcomes of male breast cancer differ from those of female breast cancer, then we need more studies that focus on men with the disease,” Dr. Shu continued. These studies should include multiple outcomes, such as cancer remissionrecurrence, and death rates from breast cancer and all causes, she added.

Read here: https://www.oncologytube.com/video/after-a-breast-cancer-diagnosis-men-may-be-more-likely-to-die-than-women-originally-published-by-the-national-cancer-institute

Up Next Autoplay
An Advocates Perspective to Increasing Funding Resources
An Advocates Perspective to Increasing Funding Resources
Category: Acute Lymphoblastic Leukemia
7 Views
kidneycancer 3 hours
Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
Category: Melanoma and Skin Cancer
0 Views
UVA Cancer Center 4 hours
Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits
Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits
Category: News
2 Views
Cancer-News 7 hours
Renal Case Presentations
Renal Case Presentations
Category: Kidney Cancer
8 Views
kidneycancer 1 day
Radiation to Prime the Immune System
Radiation to Prime the Immune System
Category: Kidney Cancer
7 Views
kidneycancer 1 day
ProVent Trial: When Will There Be Results?
ProVent Trial: When Will There Be Results?
Category: Prostate Cancer
4 Views
CURC 1 day
How is Immunotherapy Used in Prostate Cancer? @UrologyUS
How is Immunotherapy Used in Prostate Cancer? @UrologyUS
Category: Prostate Cancer
3 Views
CURC 1 day
ProVent Trial Changing AS Landscape @UrologyUS
ProVent Trial Changing AS Landscape @UrologyUS
Category: Prostate Cancer
3 Views
CURC 1 day
Current Treatment Options in the ProVent Trial
Current Treatment Options in the ProVent Trial
Category: Prostate Cancer
3 Views
CURC 1 day
Phase 3 ProVent Clinical Trial @UrologyUS
Phase 3 ProVent Clinical Trial @UrologyUS
Category: Prostate Cancer
4 Views
CURC 1 day